MVC’s WHO-Partnered Vaccine a First for Taiwan
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
Address: 92, Section 2, Chungshan North Road, Taipei City,Taiwan
Tel: (886-2)543-3535
Mackay Memorial Hospital is presently under the jurisdiction of the Presbyterian Church in Taiwan.
The hospital was established in memory of Dr. George Leslie Mackay who followed in the footsteps of his Master by coming to Taiwan with the message of salvation for all men. Even in those early days, Dr. Mackay was concerned with the total person and being able to minister to the physical, emotional and spiritual needs of each patient.
Under the leadership of Dr. Wu and former Chairman of the Board of Directors, Mou Hsiang Wang, the hospital took out a loan to erect a new hospital that would meet international standards. The first stage of this new building was completed on December 26, 1980. This modern 13 story building became the new center for patient care at Mackay. A nine story addition, which houses the medical and administrative offices, was completed on August 6, 1983. Because of the inadequacy of the hospital buildings built in 1912 and 1962 to meet the needs of patients, the board decided to demolish them and begin construction of a 16-story building to expand the present facilities.
●Area: The total land area is 13386 m2, the total area of the buildings is 49,742.36 m2.
●Scale: Medical Administration Building, Patient Care Center (2-story basement, 9-story building and 13-story building)
●Number of Beds: 1091, including 95 ICU beds
●Number of Patients: an average of more than 5000 outpatients and 350 emergency room patients, daily.
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
In an important milestone for Taiwan’s biotech industry, Diamond Biofund – one of the territory’s most well-established venture capital (VC) funds – became the first such firm to list on…
The latest pharma news from Taiwan, including Gongwin-KY’s lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan’s Industrial Technology Research Institute (ITRI) and Metagone Biotech’s glaucoma and macular…
The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical’s acquisition of Eden Biologics assets, the FDA fast track granted to the Taiwanese biomedical group United Biomedical’s…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what MVC’s competitive advantages are. At MVC we have…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how it differs from sequencing technologies in terms of cost and speed,…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious internationalization plans, and comments on the vital role that companies like Leadgene have…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the COVID-19 crisis and also explains how Quark Biosciences’ diagnostics and precision…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies. …
All country managers of multinational pharma companies need to strike the balance between having a global outlook and adapting to local culture. For BoonHuey Ee, general manager of Merck Biopharma…
See our Cookie Privacy Policy Here
